Last update 12 Jun 2026
Beijing Qihui Biomedicine Co., Ltd.

Beijing Qihui Biomedicine Co., Ltd.

Startups
| Subsidiary Company|2016|Beijing Shi, China|
www.qihuibio.com

Overview

Tags

Other Diseases
Contrast agent
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Contrast agent1
Small molecule drug1

Related

1
Drugs associated with Beijing Qihui Biomedicine Co., Ltd.
Sulfur Hexafluoride
Target-
Mechanism
Ultrasonography enhancers
Active Org.
Bracco Diagnostics, Inc. [+4]
Originator Org.
Bracco International BV
Active Indication
Breast Diseases [+7]
Inactive Indication
Coronary Artery Disease [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
European Union [+3]
First Approval Date26 Mar 2001
1
Clinical Trials associated with Beijing Qihui Biomedicine Co., Ltd.
CTR20260791
/ RecruitingPhase 1
注射用六氟化硫微泡用于超声造影判断输卵管通畅性的安全性和有效性研究
[Translation] Safety and efficacy study of injectable sulfur hexafluoride microbubbles for use in ultrasound imaging to determine fallopian tube patency.
100 Clinical Results associated with Beijing Qihui Biomedicine Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Qihui Biomedicine Co., Ltd.
Login to view more data
100 Deals associated with Beijing Qihui Biomedicine Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Qihui Biomedicine Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Sulfur Hexafluoride
Contrast agents
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free